Casey Lynch - Chief Executive Officer, Director at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
QNCX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Casey Lynch since 13 Feb 2025

Holdings reported by Casey Lynch for Quince Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 978,774 $920,048 $0.9400 18 Nov 2021 By the Zachary and Casey Lynch Living Trust dated February 24, 2009
Common Stock 109,895 $103,301 $0.9400 18 Nov 2021 Direct
Common Stock 91,911 $86,396 $0.9400 18 Nov 2021 By The Casey C. Lynch 2019 Annuity Trust
Stock Option (right to buy) 440,000 03 Jan 2022 Direct Common Stock

Transactions reported by Casey Lynch for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.